Literature DB >> 33767218

An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches.

Claudie Lamoureux1,2, Charles-Antoine Guilloux1, Clémence Beauruelle1,2, Stéphanie Gouriou1, Sophie Ramel3, Anne Dirou3, Jean Le Bihan3, Krista Revert3, Thomas Ropars3, Rosyne Lagrafeuille1, Sophie Vallet1,2, Rozenn Le Berre1,4, Emmanuel Nowak5, Geneviève Héry-Arnaud6,7.   

Abstract

Strict anaerobes are undeniably important residents of the cystic fibrosis (CF) lung but are still unknowns. The main objectives of this study were to describe anaerobic bacteria diversity in CF airway microbiota and to evaluate the association with lung function. An observational study was conducted during eight months. A hundred and one patients were enrolled in the study, and 150 sputum samples were collected using a sterile sample kit designed to preserve anaerobic conditions. An extended-culture approach on 112 sputa and a molecular approach (quantitative PCR targeting three of the main anaerobic genera in CF lung: Prevotella, Veillonella, and Fusobacterium) on 141 sputa were developed. On culture, 91.1% of sputa were positive for at least one anaerobic bacterial species, with an average of six anaerobic species detected per sputum. Thirty-one anaerobic genera and 69 species were found, which is the largest anaerobe diversity ever reported in CF lungs. Better lung function (defined as Forced Expiratory Volume in one second > 70%) was significantly associated with higher quantification of Veillonella. These results raise the question of the potential impact of anaerobes on lung function.

Entities:  

Year:  2021        PMID: 33767218     DOI: 10.1038/s41598-021-85592-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  42 in total

1.  Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.

Authors:  Marianne S Muhlebach; Joseph E Hatch; Gisli G Einarsson; Stef J McGrath; Deirdre F Gilipin; Gillian Lavelle; Bojana Mirkovic; Michelle A Murray; Paul McNally; Nathan Gotman; Sonia Davis Thomas; Matthew C Wolfgang; Peter H Gilligan; Noel G McElvaney; J Stuart Elborn; Richard C Boucher; Michael M Tunney
Journal:  Eur Respir J       Date:  2018-07-11       Impact factor: 16.671

2.  Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.

Authors:  Martina Ulrich; Isabelle Beer; Peter Braitmaier; Michaela Dierkes; Florian Kummer; Bernhard Krismer; Ulrike Schumacher; Ute Gräpler-Mainka; Joachim Riethmüller; Peter Ø Jensen; Thomas Bjarnsholt; Niels Høiby; Gabriel Bellon; Gerd Döring
Journal:  Thorax       Date:  2010-09-29       Impact factor: 9.139

3.  Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication.

Authors:  Kangmin Duan; Carol Dammel; Jeffrey Stein; Harvey Rabin; Michael G Surette
Journal:  Mol Microbiol       Date:  2003-12       Impact factor: 3.501

4.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

5.  Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens.

Authors:  H J Jansen; D Grenier; J S Van der Hoeven
Journal:  Oral Microbiol Immunol       Date:  1995-06

6.  Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

Authors:  D Worlitzsch; C Rintelen; K Böhm; B Wollschläger; N Merkel; M Borneff-Lipp; G Döring
Journal:  Clin Microbiol Infect       Date:  2009-01-22       Impact factor: 8.067

7.  Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis.

Authors:  Katherine O'Neill; Judy M Bradley; Elinor Johnston; Stephanie McGrath; Leanne McIlreavey; Stephen Rowan; Alastair Reid; Ian Bradbury; Gisli Einarsson; J Stuart Elborn; Michael M Tunney
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 8.  The Microbiome in Cystic Fibrosis.

Authors:  Yvonne J Huang; John J LiPuma
Journal:  Clin Chest Med       Date:  2015-12-23       Impact factor: 2.878

9.  Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.

Authors:  Lisa A Carmody; Lindsay J Caverly; Bridget K Foster; Mary A M Rogers; Linda M Kalikin; Richard H Simon; Donald R VanDevanter; John J LiPuma
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

10.  Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation.

Authors:  Elise S Cowley; Sebastian H Kopf; Alejandro LaRiviere; Wiebke Ziebis; Dianne K Newman
Journal:  MBio       Date:  2015-07-28       Impact factor: 7.867

View more
  5 in total

1.  Genomic Insights into the Distribution of Peptidases and Proteolytic Capacity among Prevotella and Paraprevotella Species.

Authors:  Amlan Kumar Patra; Zhongtang Yu
Journal:  Microbiol Spectr       Date:  2022-04-04

2.  Extended Bacteria Culture-Based Clustering Identifies a Phenotype Associating Increased Cough and Enterobacterales in Stable Chronic Obstructive Pulmonary Disease.

Authors:  Anaëlle Muggeo; Jeanne-Marie Perotin; Audrey Brisebarre; Sandra Dury; Valérian Dormoy; Claire Launois; Julien Ancel; Pauline Mulette; Christophe de Champs; Gaëtan Deslée; Thomas Guillard
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

3.  Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection.

Authors:  Lydia-Ann J Ghuneim; Ruma Raghuvanshi; Kerri A Neugebauer; Douglas V Guzior; Martin H Christian; Bella Schena; Jeremiah M Feiner; Alicia Castillo-Bahena; Jenna Mielke; Marc McClelland; Douglas Conrad; Isaac Klapper; Tianyu Zhang; Robert A Quinn
Journal:  ISME J       Date:  2022-05-21       Impact factor: 11.217

4.  Ruthenium(II) Polypyridyl Complexes for Antimicrobial Photodynamic Therapy: Prospects for Application in Cystic Fibrosis Lung Airways.

Authors:  Raphaëlle Youf; Adeel Nasir; Mareike Müller; Franck Thétiot; Tanguy Haute; Rosy Ghanem; Ulrich Jonas; Holger Schönherr; Gilles Lemercier; Tristan Montier; Tony Le Gall
Journal:  Pharmaceutics       Date:  2022-08-10       Impact factor: 6.525

5.  Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?

Authors:  Claudie Lamoureux; Charles-Antoine Guilloux; Elise Courteboeuf; Stéphanie Gouriou; Clémence Beauruelle; Geneviève Héry-Arnaud
Journal:  Microorganisms       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.